Silvia Pisani is currently a researcher at the Department of Drug Sciences, University of Pavia and at the IRCCS Policlinic San Matteo (Pavia). She obtained her degrees in Pharmacy and in Pharmaceutical Chemistry and Technology from the university of Pavia. She received her PhD in Chemical and Pharmaceutical Sciences from the University of Pavia in 2019. Moreover, she obtained a second level master's degree in “Mesenchymal cells in regenerative medicine and cell factory management” from the University of Torino. Her research involves electrospinning and rapid prototyping techniques for the manufacturing of 3D-scaffolds for tissue regeneration and drug delivery. She also works in the field of head and neck cancer therapy via exploiting electrochemotherapy and nanotechnology synergism. She was involved in the NFFA- Europe (Horizon 2020 EU) project at FORTH (Foundation for Research and Technology-Hellas), Crete (Greece). She has been working with the research groups of Prof. Kit Parker DBG, Harvard School of Engineering and Applied Sciences, Boston, USA, and Prof. Adriele Prina-Mello’s Lab, the School of Medicine, Trinity College.